Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | LHX2 |
| Upstream (Parents) |
|---|
| (<<) VTN → LHX2 |
| (<<) NR1I3 → LHX2 |
| (<<) SALL1 → LHX2 |
| (<<) NR1H4 → LHX2 |
| (<<) CUX2 → LHX2 |
| (<<) ONECUT1 → LHX2 |
| (<<) GATA4 → LHX2 |
| (<<) ATF5 → LHX2 |
| (<<) TCF21 → LHX2 |
| (<<) CSDA → LHX2 |
| (<<) E2F8 → LHX2 |
| (<<) PEG3 → LHX2 |
| Downstream (Children) |
|---|
| LHX2 → SOX5 (>>) |
| LHX2 → TBX1 (>>) |
| LHX2 → OVOL1 (>>) |
| LHX2 → HESX1 (>>) |
| LHX2 → MMP14 (>>) |
| LHX2 → TP63 (>>) |
| LHX2 → REST (>>) |
| LHX2 → RFXAP (>>) |
| LHX2 → MECOM (>>) |
| LHX2 → SIM1 (>>) |
| LHX2 → ZNF3 (>>) |
| LHX2 → MYCN (>>) |
| LHX2 → FOXI1 (>>) |
| LHX2 → ZSCAN2 (>>) |
| LHX2 → ALX3 (>>) |
| LHX2 → SPIB (>>) |
| LHX2 → NR2F1 (>>) |
| LHX2 → HOXB3 (>>) |
| LHX2 → KLF4 (>>) |
| LHX2 → ONECUT2 (>>) |
| LHX2 → SMAD4 (>>) |
| LHX2 → NFYA (>>) |
